Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer - PubMed (original) (raw)
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer
Tyvin Rich et al. Clin Cancer Res. 2005.
Abstract
Purpose: Incapacitating symptom burden in cancer patients contributes to poor quality of life (QOL) and can influence treatment outcomes because of poor tolerance to therapy. In this study, the role of circulating cytokines in the production symptoms in cancer patients is evaluated.
Experimental design: Eighty patients with metastatic colorectal cancer with either normal (group I, n = 40) or dampened (group II, n = 40) 24-hour rest/activity patterns measured by actigraphy were identified. Actigraphy patterns were correlated with QOL indices, serum cortisol obtained at 8:00 a.m. and 4:00 p.m. and with serum levels of transforming growth factor-alpha, tumor necrosis factor-alpha, and interleukin 6 (IL-6) obtained at 8:00 a.m. and analyzed in duplicate by ELISA. Cytokine levels and survival were also correlated.
Results: Group II patients had significantly higher pre treatment levels of all three cytokines, displayed significantly poorer emotional and social functioning, had higher fatigue, more appetite loss, and poorer performance status compared with group I patients. Transforming growth factor-alpha (TGF-alpha) and IL-6 were significantly increased in the patients with WHO performance status >1 and in those with appetite loss. Fatigue was significantly associated with elevated TGF-alpha only. IL-6 was increased in those patients with extensive liver involvement and multiple organ replacement, and it was significantly correlated with dampened cortisol rhythm. In a multivariate analysis, IL-6 was correlated with poor treatment outcome.
Conclusions: Significant correlations were found between serum levels of TGF-alpha and IL-6, circadian patterns in wrist activity and serum cortisol and tumor-related symptoms in patients with metastatic colorectal cancer. These data support the hypothesis that some cancer patient's symptoms of fatigue, poor QOL, and treatment outcome are related to tumor or host generated cytokines and could reflect cytokine effects on the circadian timing system. This interplay between cytokine signaling pathways, the hypothalamic-pituitary-adrenal axis, the autonomic nervous system, and efferent pathways of the suprachiasmatic nucleus that control circadian physiology, opens the way to new rational interventions for symptom management in cancer patients.
Similar articles
- Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M, Brera G. Lissoni P, et al. In Vivo. 2007 Jul-Aug;21(4):647-50. In Vivo. 2007. PMID: 17708360 - Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
Mussi C, Angelini C, Crippa S, Caprotti R, Fumagalli L, Motta V, Uggeri F. Mussi C, et al. Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccxxviii-ccxxxi. Hepatogastroenterology. 2003. PMID: 15244187 - Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status.
Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, Lévi F. Mormont MC, et al. Clin Cancer Res. 2000 Aug;6(8):3038-45. Clin Cancer Res. 2000. PMID: 10955782 Clinical Trial. - Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis.
Rich TA. Rich TA. J Support Oncol. 2007 Apr;5(4):167-74; discussion 176-7. J Support Oncol. 2007. PMID: 17500504 Review. - [Palliative therapy in cancer. 6. Quality of life and BRM therapy in cancer-patients].
Urushizaki I. Urushizaki I. Gan To Kagaku Ryoho. 1990 Oct;17(10):2119-29. Gan To Kagaku Ryoho. 1990. PMID: 1699499 Review. Japanese.
Cited by
- Circadian rhythm disorders in patients with advanced cancer: a scoping review.
Gouldthorpe C, Power J, Davies A. Gouldthorpe C, et al. Front Oncol. 2023 Sep 26;13:1240284. doi: 10.3389/fonc.2023.1240284. eCollection 2023. Front Oncol. 2023. PMID: 37829342 Free PMC article. Review. - Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer.
Cui Y, Han X, Liu H, Xie Q, Guan Y, Yin B, Xiao J, Feng D, Wang X, Li J, Chen J, Liu X, Li X, Nie W, Ma L, Liu H, Liang J, Li Y, Wang B, Wang J. Cui Y, et al. Front Immunol. 2023 Apr 11;14:1081790. doi: 10.3389/fimmu.2023.1081790. eCollection 2023. Front Immunol. 2023. PMID: 37114049 Free PMC article. - Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
Cheng E, Shi Q, Shields AF, Nixon AB, Shergill AP, Ma C, Guthrie KA, Couture F, Kuebler P, Kumar P, Tan B, Krishnamurthi SS, Ng K, O'Reilly EM, Brown JC, Philip PA, Caan BJ, Cespedes Feliciano EM, Meyerhardt JA. Cheng E, et al. JAMA Oncol. 2023 Mar 1;9(3):404-413. doi: 10.1001/jamaoncol.2022.6911. JAMA Oncol. 2023. PMID: 36701146 Free PMC article. - Circadian disruption and cancer- and treatment-related symptoms.
Amidi A, Wu LM. Amidi A, et al. Front Oncol. 2022 Oct 28;12:1009064. doi: 10.3389/fonc.2022.1009064. eCollection 2022. Front Oncol. 2022. PMID: 36387255 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical